Qualigen Therapeutics, Inc. (QLGN)
US — Healthcare Sector
Automate Your Wheel Strategy on QLGN
With Tiblio's Option Bot, you can configure your own wheel strategy including QLGN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol QLGN
- Rev/Share 0.0
- Book/Share 22.7569
- PB 0.1276
- Debt/Equity 0.0
- CurrentRatio 1.0111
- ROIC -8.0631
- MktCap 4747471.0
- FreeCF/Share -4899.2521
- PFCF -0.6655
- PE -0.0006
- Debt/Assets 0.0
- DivYield 0
- ROE 7.4167
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 5
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
About Qualigen Therapeutics, Inc. (QLGN)
- IPO Date 2015-06-23
- Website https://qlgntx.com
- Industry Biotechnology
- CEO Kevin A. Richardson II
- Employees 4
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.